DUBLIN, Apr. 15, 2014 /PRNewswire/ --
Research and Markets
) has announced the addition of the
report to their offering.
The analysts forecast the Global In Vitro Fertilization (IVF) market to grow at a CAGR of 12.12 percent over the period 2012-2016. One of the key factors contributing to this market growth is the high prevalence of infertility rates. The Global IVF market has also been witnessing the increase in medical tourism. However, the high cost associated with the IVF procedures could pose a challenge to the growth of this market.
The report, Global IVF Market Report, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global IVF market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Advances in assisted reproduction by understanding the mechanisms involved in embryo development is vital for improving the likelihood of success. For example, researchers in the University of Gothenburg, Sweden, have identified a molecule, Cdk1, which plays an important role in egg maturation resulting in more pregnancies through the IVF method.
In research undertaken at Oxford University in the UK, scientists have developed a method, which was tested in mice, for selecting the most suitable egg that could result in pregnancy, another way of minimizing the need to use many cycles of IVF.
It is perceived that new technology development and treatment options could potentially increase the number of fertile eggs of women in older age-groups, which could benefit them by avoiding the cost associated with purchasing eggs and result in offspring with a very close genetic resemblance.
According to the report, one of the major drivers in this market is the high prevalence of infertility rates in the human population across the globe. Various factors contributing to high infertility rates include unhealthy lifestyles, smoking, obesity, and environmental factors. It is estimated that one out of every 25 men show low sperm count every year.
Further, the report states that one of the major challenges in this market is the high cost associated with IVF procedures. The high cost is mainly due to the laborious process in the IVF procedure, which includes hormone injections, egg retrieval, in vitro fertilization, embryo selection, and embryo culture. Further, most of these IVF procedures involve multiple cycles, which adds to the total cost.
Key Topics Covered:
01. Executive Summary
02. List of Abbreviations
04. Market Research Methodology
05. Scope of the Report
06. Market Landscape
07. Market Segmentation
08. Geographical Segmentation
09. Key Leading Countries
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
18. Other Reports in this Series
- Biogenics Inc.
- Cook Medical Inc
- Cooper Surgical Inc
- Cryologic Pvt Ltd
- Gynemed GmbH & Co KG
- Gynetics Medical Products N.V
- IVFtech ApS
- Irvine Scientific
- Kitazato Corp
- LifeGlobal Group LLC
- MTG Medical Technology Vertriebs-GmbH
- Microtech IVF s.r.o
- Nidacon International AB
- Ovascience Inc
- Smiths Medicals International Ltd
- SoMATEX Medical Technologies GmbH
- Sperm Processor Pvt Ltd
- Vitrolife AB.
- Xytex Cryo International Ltd.
For more information visit http://www.researchandmarkets.com/research/32hdr3/global_in_vitro
Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets